This inventor holds 3 USPTO granted patents. Top assignee: Intervet Inc.. Active years: 2010-2011.
Company Filing History:
Years Active: 2010-2011
Title: Richard M Synenki: Innovator in Vaccine Development
Introduction
Richard M Synenki is a notable inventor based in San Diego, CA. He has made significant contributions to the field of vaccine development, holding a total of 3 patents. His work focuses on creating innovative solutions to enhance public health.
Latest Patents
One of Richard's latest patents involves recombinant attenuated clostridium organisms and vaccines. This invention discloses attenuated organisms that express a substantially nontoxic alpha-toxin. The expressed alpha-toxin is a deletion mutein that, relative to the alpha-toxin of the mature alpha-toxin of strain 13, is missing at least nine consecutive amino acid residues, including His. The invention also includes attenuated organisms that encode the muteins, as well as the use of such attenuated organisms as vaccines.
Career Highlights
Richard M Synenki is currently associated with Intervet Inc., where he continues to work on groundbreaking research in vaccine technology. His expertise and innovative approach have positioned him as a key figure in his field.
Collaborations
Throughout his career, Richard has collaborated with notable colleagues, including Mark D Cochran and Stephen V Lair. These partnerships have further enriched his research and development efforts.
Conclusion
Richard M Synenki's contributions to vaccine development through his patents and collaborations highlight his commitment to advancing public health. His innovative work continues to make a significant impact in the field.